Cell cycle Regulation of G1/S transition (part 1)

Pathway network for the Cell cycle Regulation of G1/S transition (part 1) SuperPath

Sources:
  • GeneGo (Thomson Reuters)
  • QIAGEN

Pathways in the Cell cycle Regulation of G1/S transition (part 1) SuperPath

#NameSourceGenes
1Cell cycle Regulation of G1/S transition (part 1)GeneGo (Thomson Reuters)
2Mitotic Roles of Polo Like KinasesQIAGEN
3Cell cycle Role of SCF complex in cell cycle regulationGeneGo (Thomson Reuters)
4Cell cycle ESR1 regulation of G1/S transitionGeneGo (Thomson Reuters)
5Immune response MIF-JAB1 signalingGeneGo (Thomson Reuters)

Gene overlap in member pathways for Cell cycle Regulation of G1/S transition (part 1) SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Cell cycle Regulation of G1/S transition (part 1) SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Loeys-dietz syndromeEnrichmentSMAD2, SMAD3, TGFB2, TGFBR1, TGFBR29.54
2Familial thoracic aortic aneurysm and aortic dissectionEnrichmentSMAD2, SMAD3, SMAD4, TGFB2, TGFBR1, TGFBR27.23
3Loeys-dietz syndrome 1EnrichmentSMAD2, TGFBR1, TGFBR26.98
4Gastric cancerEnrichmentBRCA1, CDK4, CDKN2A, CHEK2, SMAD45.74
5Multiple endocrine neoplasia, type iEnrichmentCDKN1A, CDKN1B, CDKN2B5.44
6Pancreatic cancerEnrichmentBRCA1, CDKN2A, CHEK2, SMAD45.25
7Marfan syndromeEnrichmentTGFB2, TGFBR1, TGFBR24.91
8Loeys-dietz syndrome 4EnrichmentTGFB2, TGFB34.81
9Loeys-dietz syndrome 2EnrichmentTGFBR1, TGFBR24.65
10Inherited cancer-predisposing syndromeEnrichmentBRCA1, CDK4, CDKN1B, CDKN2A, CHEK2, SMAD44.41
11Colorectal cancerEnrichmentBRCA1, CCND1, CHEK2, FBXW7, SMAD44.23
12Melanoma, cutaneous malignant 1EnrichmentCDK4, CDKN2A, CDKN2B4.17
13Ehlers-danlos syndromeEnrichmentSMAD3, TGFB2, TGFBR24.02
14Aortic aneurysmEnrichmentSMAD3, TGFBR13.87
15Li-fraumeni syndromeEnrichmentCDKN2A, CHEK23.48
16Bladder cancerEnrichmentBRCA1, CDKN1A, CDKN2A3.45
17MelanomaEnrichmentCDKN2A, CHEK23.00
18Breast cancerEnrichmentCKS1B, ESR1, JUN2.99
19Uterine corpus cancerEnrichmentBRCA1, CHEK22.92
20Ovarian cancerEnrichmentBRCA1, CDKN1B, CDKN2A, CHEK22.86
21Breast-ovarian cancer, familial 1EnrichmentBRCA1, CHEK22.77
22Lynch syndromeEnrichmentCHEK2, TGFBR22.64
23Semilobar holoprosencephalyEnrichmentSMC1A, STAG22.64
24Melanoma, cutaneous malignant 3EnrichmentCDK42.63
25Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3EnrichmentCCND22.63
26Glucocorticoid resistance, generalizedEnrichmentNR3C12.63
27Neurodevelopmental, jaw, eye, and digital syndromeEnrichmentFBXW112.63
28Progesterone resistanceEnrichmentPGR2.63
29Neuroendocrine tumorEnrichmentCDKN1B2.63
30Parkinson disease 5, autosomal dominantEnrichmentUCHL12.63
31Developmental delay, hypotonia, and impaired languageEnrichmentFBXW72.63
32Microcephaly 12, primary, autosomal recessiveEnrichmentCDK62.58
33Noonan syndrome 13EnrichmentMAPK12.58
34Brunet-wagner neurodevelopmental syndromeEnrichmentRBL22.58
35Trilateral retinoblastomaEnrichmentRB12.58
36Lung oat cell carcinomaEnrichmentRB12.58
37Meier-gorlin syndrome 4EnrichmentCDT12.50
38Ferguson-bonni neurodevelopmental syndromeEnrichmentANAPC72.50
39Developmental and epileptic encephalopathy 109EnrichmentFZR12.50
40Rothmund-thomson syndrome, type 1EnrichmentANAPC12.50
41Oocyte/zygote/embryo maturation arrest 21EnrichmentCHEK12.50
42Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual developmentEnrichmentKIF112.40
43Developmental and epileptic encephalopathy 85 with or without midline brain defectsEnrichmentSMC1A2.40
44Holoprosencephaly 13, x-linkedEnrichmentSTAG22.40
45Spinocerebellar ataxia 12EnrichmentPPP2R2B2.40
46Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual developmentEnrichmentPTPA2.40
47Oocyte/zygote/embryo maturation arrest 14EnrichmentCDC202.40
48Mullegama-klein-martinez syndromeEnrichmentSTAG22.40
49Houge-janssens syndrome 4EnrichmentPPP2R5C2.40
50Houge-janssens syndrome 2EnrichmentPPP2R1A2.40
51Tumor predisposition syndrome 4EnrichmentCHEK22.40
52Camurati-engelmann disease 2EnrichmentTGFB22.40
53Loeys-dietz syndrome 5EnrichmentTGFB32.40
54Xq25 microduplication syndromeEnrichmentSTAG22.40
55LeiomyosarcomaEnrichmentCHEK22.40
56Ppp2r1a-related neurodevelopmental disorderEnrichmentPPP2R1A2.40
57Endometrial cancerEnrichmentBRCA1, CHEK22.35
58Galactosemia iiEnrichmentNR3C12.33
59Immunodeficiency, common variable, 12, with autoimmunityEnrichmentNFKB12.33
60Multiple endocrine neoplasia, type ivEnrichmentCDKN1B2.33
61Spastic paraplegia 79b, autosomal recessiveEnrichmentUCHL12.33
62Autoinflammatory disease, familial, behcet-like 3EnrichmentRELA2.33
63Rela fusion-positive ependymomaEnrichmentRELA2.33
64Hereditary spastic paraplegia 79aEnrichmentUCHL12.33
65Spastic paraplegia 79a, autosomal dominant, with ataxiaEnrichmentUCHL12.33
66Primary mediastinal large b-cell lymphomaEnrichmentXPO12.33
67Common variable immunodeficiency 12EnrichmentNFKB12.33
68Submucosal cleft palateEnrichmentUBB2.33
69Cleft hard palateEnrichmentUBB2.33
70Palmoplantar keratoderma, punctate type iiEnrichmentBRCA12.32
71Multiple self-healing squamous epitheliomaEnrichmentTGFBR12.32
72Infant-type hemispheric gliomaEnrichmentBRCA12.32
73Colorectal cancer, hereditary nonpolyposis, type 6EnrichmentTGFBR22.32
74Loeys-dietz syndrome 6EnrichmentSMAD22.32
75Congenital heart defects, multiple types, 8, with or without heterotaxyEnrichmentSMAD22.32
76Cdkn2a cancer predispositionEnrichmentCDKN2A2.32
77Heritable thoracic aortic diseaseEnrichmentSMAD42.32
78Primary peritoneal carcinomaEnrichmentBRCA12.32
79Burkitt lymphomaEnrichmentMYC2.28
80Chromosome 13q14 deletion syndromeEnrichmentRB12.28
81Familial retinoblastomaEnrichmentRB12.28
82Vexas syndromeEnrichmentUBA12.20
83Loeys-dietz syndrome 3EnrichmentSMAD32.20
84Spinal muscular atrophy, x-linked 2EnrichmentUBA12.20
85Uvula, bifidEnrichmentUBB2.15
86Cleft soft palateEnrichmentUBB2.15
87Dedifferentiated liposarcomaEnrichmentCDK42.15
88Well-differentiated liposarcomaEnrichmentCDK42.15
89Lung cancerEnrichmentCHEK2, PPP2R1B2.15
90RetinoblastomaEnrichmentRB12.10
91Osteogenic sarcomaEnrichmentRB12.10
92Estrogen resistanceEnrichmentESR12.10
93Woolly hair, autosomal recessive 3EnrichmentRB12.10
94Hypotrichosis 8EnrichmentRB12.10
95High-grade b-cell lymphoma double-hit/triple-hitEnrichmentMYC2.10
96Squamous cell carcinomaEnrichmentRB12.10
97Migraine without auraEnrichmentESR12.10
98Bone osteosarcomaEnrichmentRB12.10
99Anemia, congenital dyserythropoietic, type iiiaEnrichmentKIF232.10
100Camurati-engelmann disease 1EnrichmentTGFB12.10
101Microcephaly and chorioretinopathy, autosomal recessive, 1EnrichmentKIF112.10
102Cornelia de lange syndrome 2EnrichmentSMC1A2.10
103Congenital heart defects, multiple types, 3EnrichmentCHEK22.10
104Inflammatory bowel disease, immunodeficiency, and encephalopathyEnrichmentTGFB12.10
105Microcephaly and chorioretinopathy 1EnrichmentKIF112.10
106Camurati-engelmann diseaseEnrichmentTGFB12.10
107Li-fraumeni syndrome 1EnrichmentCHEK22.10
108SarcomaEnrichmentCHEK22.10
109Houge-janssens syndrome 3EnrichmentPPP2CA2.10
110Prostate cancerEnrichmentBRCA1, CHEK22.07
111Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1EnrichmentCCND22.03
112Mantle cell lymphomaEnrichmentCCND12.03
113Primary hyperparathyroidismEnrichmentCDKN1B2.03
114Systemic-onset juvenile idiopathic arthritisEnrichmentMIF2.03
115Melanoma-astrocytoma syndromeEnrichmentCDKN2A2.02
116Myhre syndromeEnrichmentSMAD42.02
117Juvenile polyposis/hereditary hemorrhagic telangiectasia syndromeEnrichmentSMAD42.02
118Microvascular complications of diabetes 5EnrichmentTGFBR22.02
119Melanoma, cutaneous malignant 2EnrichmentCDKN2A2.02
120Houge-janssens syndrome 1EnrichmentPPP2R5D2.02
121Fanconi anemia, complementation group sEnrichmentBRCA12.02
122Pancreatic cancer 4EnrichmentBRCA12.02
123Melanoma-pancreatic cancer syndromeEnrichmentCDKN2A2.02
124Inflammatory breast carcinomaEnrichmentBRCA12.02
125Peritoneum cancerEnrichmentBRCA12.02
126Bilateral breast cancerEnrichmentBRCA12.02
127Connective tissue diseaseEnrichmentSMAD3, TGFBR21.99
128Small cell cancer of the lungEnrichmentRB11.98
129Chromosome 22q11.2 deletion syndrome, distalEnrichmentMAPK11.98
130Lynch syndrome 4EnrichmentRB11.98
131Congenital generalized lipodystrophyEnrichmentFOS1.98
132Arthrogryposis multiplex congenita 3, myogenic typeEnrichmentESR11.98
133Von hippel-lindau syndromeEnrichmentCCND11.93
134Rheumatoid arthritis, systemic juvenileEnrichmentMIF1.93
135Pervasive developmental disorderEnrichmentFBXW71.93
136Rare pervasive developmental disorderEnrichmentFBXW71.93
137Male infertility due to gonadal dysgenesis or sperm disorderEnrichmentCHEK11.90
138MicrocephalyEnrichmentKIF11, KIF23, SMC1A1.89
139Histiocytoid hemangiomaEnrichmentFOS1.88
140Juvenile polyposis syndromeEnrichmentSMAD41.84
141Hemoglobin c diseaseEnrichmentCHEK21.80
142Common variable immunodeficiencyEnrichmentNFKB11.79
143Lennox-gastaut syndromeEnrichmentMAPK101.73
144Isolated split hand-split foot malformationEnrichmentBTRC1.73
145Hereditary breast carcinomaEnrichmentBRCA1, CHEK21.73
146Polyposis syndrome, hereditary mixed, 1EnrichmentBRCA11.72
147CholangiocarcinomaEnrichmentBRCA11.72
148Arrhythmogenic right ventricular dysplasia, familial, 1EnrichmentTGFB31.70
149Arrhythmogenic right ventricular dysplasia 1EnrichmentTGFB31.70
150Primary hyperaldosteronismEnrichmentNR3C11.68
151Leukemia, chronic lymphocyticEnrichmentCCND11.63
152Ciliary dyskinesia, primary, 3EnrichmentNFKB11.63
153Atrial septal defect 1EnrichmentTGFB21.63
154Wilms tumor 5EnrichmentCHEK21.63
155Wiedemann-steiner syndromeEnrichmentSMC1A1.63
156Inflammatory bowel disease 25, autosomal recessiveEnrichmentTGFB11.63
157Il10-related early-onset inflammatory bowel diseaseEnrichmentTGFB11.63
158Syndromic rod-cone dystrophyEnrichmentKIF111.63
159Breast-ovarian cancer, familial 2EnrichmentBRCA11.62
160Generalized juvenile polyposis/juvenile polyposis coliEnrichmentSMAD41.62
161Early-onset parkinson's diseaseEnrichmentUCHL11.55
162Familial thoracic aortic aneurysm and dissectionEnrichmentSMAD31.55
163Adrenocortical carcinomaEnrichmentCDKN2A1.55
164Lung squamous cell carcinomaEnrichmentCDKN2A1.55
165Classic ehlers-danlos syndromeEnrichmentTGFBR11.55
166Hereditary breast ovarian cancer syndromeEnrichmentBRCA1, CHEK21.54
167Migraine with or without aura 1EnrichmentESR11.54
168Specific learning disabilityEnrichmentMAPK11.54
169Meier-gorlin syndrome 1EnrichmentCDT11.50
170Lip and oral cavity carcinomaEnrichmentRB11.50
171Rett syndrome, congenital variantEnrichmentSMC1A1.50
172Esophageal cancerEnrichmentTGFBR21.48
173Gallbladder cancerEnrichmentSMAD41.48
174Hereditary hemorrhagic telangiectasiaEnrichmentSMAD41.48
175B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentCDKN2A1.48
176Cornelia de lange syndrome 1EnrichmentSMC1A1.45
177Colonic benign neoplasmEnrichmentCHEK21.45
178Cornelia de lange syndromeEnrichmentSMC1A1.45
179Lung cancer susceptibility 3EnrichmentRB11.44
180Lynch syndrome 1EnrichmentCHEK21.41
181Familial colorectal cancer type xEnrichmentCHEK21.37
182Aortic aneurysm, familial thoracic 1EnrichmentSMAD31.36
183Polycystic liver diseaseEnrichmentCDC25A1.35
184Autosomal dominant polycystic liver diseaseEnrichmentCDC25A1.35
185Heart, malformation ofEnrichmentMAPK11.33
186Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variantEnrichmentTGFB31.33
187Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variantEnrichmentTGFB31.33
188Nk-cell enteropathyEnrichmentCHEK21.30
189Pectus excavatumEnrichmentTGFBR11.29
190Leukemia, acute lymphoblasticEnrichmentCDKN2A1.29
191Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variantEnrichmentTGFB31.26
192Myocardial infarctionEnrichmentESR11.25
193Wilms tumor 1EnrichmentCHEK21.24
194Precursor t-cell acute lymphoblastic leukemiaEnrichmentMYC1.23
195Periventricular nodular heterotopiaEnrichmentBRCA11.19
196Alobar holoprosencephalyEnrichmentSTAG21.18
197Cystic fibrosisEnrichmentMIF1.14
198Diffuse large b-cell lymphomaEnrichmentCHEK21.14
199RhabdomyosarcomaEnrichmentBRCA11.13
200Primary autosomal recessive microcephalyEnrichmentCDK61.09
201Visceral heterotaxyEnrichmentLEFTY21.08
202Complex neurodevelopmental disorderEnrichmentFBXW11, PPP2CA0.92
203Myeloma, multipleEnrichmentCCND10.91
204Fanconi anemia, complementation group aEnrichmentBRCA10.81
205Undetermined early-onset epileptic encephalopathyEnrichmentFZR10.79
206ThrombocytopeniaEnrichmentSMAD40.69
207Primary ovarian insufficiencyEnrichmentCHEK20.68
208Congenital nervous system abnormalityEnrichmentSMC1A0.46
209Nervous system diseaseEnrichmentSMC1A0.46
210Retinitis pigmentosaEnrichmentKIF110.24
211Hereditary retinal dystrophyEnrichmentKIF110.16
212Fundus dystrophyEnrichmentKIF110.16

Loading...
Loading...
Loading...